◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
万邦医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
+Revenue 379.0M 342.0M 261.0M 211.0M 139.0M 103.0M 105.0M
Revenue Growth % 10.8% 31.0% 23.7% 51.8% 35.0% -1.9% --
Total Revenue 379.0M 342.0M 261.0M 211.0M 139.0M 103.0M 105.0M
Cost Of Revenue 229.0M 175.0M 129.0M 99.8M 61.5M 53.8M 57.3M
+Gross Profit 150.0M 167.0M 132.0M 111.2M 77.5M 49.2M 47.7M
Gross Margin % 39.6% 48.8% 50.6% 52.7% 55.7% 47.8% 45.4%
Total Operating Cost 326.0M 235.0M 165.0M 128.0M 82.5M 77.7M 74.5M
Selling Expenses 4.9M 4.5M 4.4M 4.0M 2.9M 4.8M 2.8M
Admin Expenses 26.9M 20.7M 12.5M 11.4M 9.0M 11.3M 8.6M
Rd Expenses 60.7M 34.5M 16.0M 10.3M 7.8M 6.7M 5.6M
Finance Expenses -3.1M -4.6M -889,300 -414,600 -83,500 232,000 -205,300
+Operating Income 87.0M 119.0M 106.0M 87.2M 59.4M 28.3M 30.3M
Operating Margin % 23.0% 34.8% 40.6% 41.3% 42.8% 27.5% 28.9%
Non Operating Income 2.5M 757,600 5.1M 7.4M 3.4M 2.2M 1.8M
Non Operating Expenses 50,600 118,900 5,800 215,200 74,200 102,800 200.00
Investment Income 21.2M 2.4M 3.2M 1.9M 1.2M 371,600 76,300
Fair Value Change Income 7.0M 3.8M -- -- -- 221,600 --
Asset Disposal Income 16,400 -- -- -- -- -- --
Asset Impairment Loss 2.0M 1.5M 843,500 911,500 338,800 -- 86,500
Other Income 5.5M 5.9M 6.6M 1.9M 1.7M 2.4M --
Income Before Tax 89.5M 120.0M 111.0M 94.3M 62.8M 30.5M 32.1M
Income Tax 4.0M 11.6M 12.4M 12.5M 8.2M 4.0M 4.3M
+Net Income 85.5M 108.0M 98.7M 81.9M 54.5M 26.5M 27.8M
Net Margin % 22.6% 31.6% 37.8% 38.8% 39.2% 25.7% 26.5%
Net Income Attributable 85.5M 108.0M 98.7M 81.9M 54.5M 26.6M 27.9M
Minority Interest -- -- -- -- -- -111,400 -113,400
Eps Basic 1.28 2.00 1.97 1.64 1.14 0.61 0.74
Eps Diluted 1.28 2.00 1.97 -- -- 0.61 0.74
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
Cash And Equivalents 179.0M 253.0M 186.0M 161.0M 120.0M 5.6M 20.9M
Trading Financial Assets 1.0B 903.0M -- -- -- 29.2M --
Accounts Receivable 63.9M 53.0M 33.4M 14.8M 7.2M 13.0M 10.3M
Notes Receivable 12.0M 6.8M 8.8M 7.0M 13.9M 2.7M 1.7M
Notes And Accounts Receivable 75.9M 59.8M 42.3M 21.9M 21.1M 15.6M 12.0M
Prepayments 9.9M 8.6M 1.1M 2.4M 3.0M 3.2M 3.3M
Inventory 2.0M 666,500 444,000 179,800 377,700 235,300 244,300
Total Current Assets 1.4B 1.4B 286.0M 226.0M 164.0M 54.0M 40.4M
Fixed Assets -- 150.0M 40.3M 32.8M 32.1M 23.2M 22.9M
Fixed Assets Total 175.0M 150.0M 40.3M 32.8M 32.1M 23.2M 22.9M
Construction In Progress -- -- 56.9M 9.2M 555,500 -- --
Construction In Progress Total 1.7M -- 56.9M 9.2M 555,500 -- --
Intangible Assets 11.6M 12.0M 10.1M 9.5M 791,500 1.1M 1.0M
Long Term Deferred Expenses 2.7M 5.5M 3.3M 2.6M 2.1M 1.3M 1.5M
Total Non Current Assets 201.0M 182.0M 118.0M 57.7M 36.1M 30.4M 26.8M
Total Assets 1.6B 1.5B 405.0M 284.0M 201.0M 84.4M 67.2M
Short Term Borrowings -- -- -- -- -- -- 5.0M
Accounts Payable 37.8M 27.0M 27.4M 12.1M 3.9M 3.2M 5.2M
Advance Receipts -- -- -- 10,700 -- 17.2M 21.6M
Contract Liabilities 19.7M 20.7M 17.6M 16.5M 27.1M -- --
Total Current Liabilities 74.7M 66.9M 65.2M 44.3M 44.4M 28.5M 48.3M
Long Term Borrowings -- -- -- -- -- -- 157,100
Total Non Current Liabilities 15.7M 13.6M 7.7M 6.5M 5.1M 3.0M 1.9M
Total Liabilities 90.4M 80.6M 73.0M 50.8M 49.5M 31.5M 50.2M
Paid In Capital 66.7M 66.7M 50.0M 50.0M 50.0M 10.0M 1.0M
Capital Reserve 1.0B 1.0B 29.8M 29.8M 29.8M 26.1M --
Surplus Reserve 40.5M 33.1M 23.6M 14.6M 7.2M 2.3M 3.7M
Retained Earnings 372.0M 327.0M 228.0M 138.0M 64.0M 14.4M 12.0M
Minority Equity -- -- -- -- -- -- 286,600
Equity Attributable 1.5B 1.5B 332.0M 233.0M 151.0M 52.9M 16.7M
Total Equity 1.5B 1.5B 332.0M 233.0M 151.0M 52.9M 17.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
Cash From Sales 353.0M 309.0M 231.0M 186.0M 120.0M 90.8M 101.0M
Total Operating Cash Inflow 365.0M 324.0M 244.0M 197.0M 129.0M 96.2M 103.0M
Cash Paid For Goods 193.0M 154.0M 102.0M 80.6M 42.0M 40.7M 44.1M
Cash Paid To Employees 78.5M 65.0M 43.4M 29.5M 20.3M 18.4M 13.1M
Taxes Paid 11.6M 14.8M 16.7M 18.5M 10.3M 7.7M 2.2M
Total Operating Cash Outflow 318.0M 252.0M 171.0M 141.0M 81.8M 77.8M 67.2M
Operating Cash Flow 46.8M 71.9M 72.3M 55.4M 47.1M 18.4M 35.9M
Total Investing Cash Inflow 1.2B 357.0M 1.1B 1.2B 402.0M 51.0M 59.1M
Total Investing Cash Outflow 1.3B 1.4B 1.1B 1.3B 379.0M 81.0M 63.9M
Investing Cash Flow -87.1M -1.0B -47.5M -13.7M 23.5M -29.9M -4.8M
Cash From Borrowings -- -- -- -- -- -- 5.0M
Dividends And Interest Paid 31.1M -- -- -- -- 4.5M 17.2M
Debt Repayments 0.00 0.00 -- -- -- 5.8M 2.6M
Total Financing Cash Inflow 0.00 1.1B -- -- 43.6M 6.6M 5.4M
Total Financing Cash Outflow 34.0M 24.8M 120,000 90,000 -- 10.3M 22.8M
Financing Cash Flow -34.0M 1.0B -120,000 -90,000 43.6M -3.7M -17.4M
Net Change In Cash -74.2M 67.3M 24.7M 41.6M 114.0M -15.2M 13.7M
Ending Cash Balance 179.0M 253.0M 186.0M 161.0M 120.0M 5.6M 20.9M
Capex 41.8M 86.0M 50.7M 15.6M 6.9M 4.2M 10.6M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...